Described are surgical implants that include releasable reinforcement, and related methods, particular example implants and methods being useful for treating pelvic tissue, cardiac tissue, and hernia, wherein the releasable reinforcement can be released (removed or disabled) during a surgical procedure to affect a mechanical property of the implant or a portion of the implant.

During a percutaneous procedure, a flexible sleeve of an annuloplasty structure is introduced into an atrium and arranged completely around an annulus as a closed loop, such that none of one or more longitudinal contracting members thereof is positioned along an anterior portion of the annulus between fibrous trigones of the valve. The annuloplasty structure is fastened to the annulus. At least a portion of a posterior portion of the annulus is tightened, while preserving a length of an anterior portion of the annulus between fibrous trigones of the valve, by contracting, using the one or more longitudinal contracting members, a longitudinal portion of the sleeve not positioned along the anterior portion of the annulus between the fibrous trigones of the valve. Thereafter, the one or more longitudinal contracting members are locked.

A gastroscopic method and instrument for treating obesity of a patient, using a device adapted to stretch a part of the stomach wall of said patient. The method comprises the steps of: inserting the device into the stomach through the esophagus, placing the device in contact with the stomach wall, and fixating the device to the stomach wall such that the device can stretch a part of the stomach wall.

Devices and related methods of use are provided for improving heart function. In one embodiment of the present disclosure, a device includes a ring-like structure configured to be secured to a heart valve; at least one elongate member extending from the ring-like structure, wherein an end of the elongate member is configured to be secured to heart geometry other than a heart valve; and an adjustment mechanism for simultaneously altering a dimension of the ring-like structure and a length of the elongate member.

A prosthetic heart valve configured to replace a native heart valve and having a support frame configured to be reshaped into an expanded form in order to receive and/or support an expandable prosthetic heart valve therein is disclosed, together with methods of using same. The prosthetic heart valve may be configured to have a generally rigid and/or expansion-resistant configuration when initially implanted to replace a native valve (or other prosthetic heart valve), but to assume a generally expanded form when subjected to an outward force such as that provided by a dilation balloon or other mechanical expander.

A tissue expansion device can be implanted temporarily beneath skin of a patient and removed upon expansion of overlying tissue. The device can include an expandable shell having a smooth or glossy outer surface and an injection port. The expandable shell can form an expandable chamber and have an anterior portion and a posterior portion. The injection port can be coupled to the anterior portion of the shell and be in fluid communication with the chamber and configured to permit injection of fluid into the chamber from a hypodermic needle. The device can have a plurality of tabs coupled to the posterior portion of the shell having one or more colors or attributes. The device can also include an orientation indicator visible along the anterior portion of the shell for assisting a clinician and orienting the device during the implantation procedure.

A method of forming an implant includes providing a preformed shell formed from at least one cured elastomeric layer. The shell includes an outer surface, an inner surface, and an opening for accessing an interior volume of the shell. The method further includes expanding the shell to an expanded state, in which the interior volume is greater than the interior volume of the shell at a time of forming the shell and forming an inner zone having at least one inner elastomeric layer on at least a portion of the inner surface of the shell, while the shell is in the expanded state, thereby forming a multi-zone shell. The method further includes reducing the interior volume of the multi-zone shell, thereby contracting the at least one inner elastomeric layer of the inner zone and causing texturing of the at least one inner elastomeric layer.

Apparatus for protection of the ear and ear canal, and related methods of use and operation. In one embodiment, the apparatus includes a selectively actuated valve which permits a varying or modulated size of aperture to be created by the wearer while the apparatus is in use, so as to accommodate varying functions, such as complete occlusion (e.g., for use in swimming or other acquatic activities such that water can be completely excluded) or partial occlusion (e.g., such that sounds can be heard by the wearer, whether in air or under water). In one implementation, the apparatus is retained within the ear canal of the wearer by virtue of the apparatus' shape and coordination with one or more natural features or contours of the anatomy in the ear region, without having to be inserted more than superficially into the outer portion of the ear canal.

An intraocular lens (IOL) implanted in a patient's eye in a cataract procedure is modified by altering the spatial refractive index profile of the IOL to remove higher order aberrations of the patient's visual system. The higher order aberrations are measured by an aberrometer, and the measured distortions on the cornea are propagated from the corneal surfaces to the IOL plane, and corrected in the IOL. This allows the choice to have high order aberration correction to be an independent choice for the patient, independent of the decision to have cataract surgery. In addition, patients with existing standard IOLs implanted may obtain the benefit of high order aberration correction at any time after implantation.

During a process of refractive index modification of an intraocular lens (IOL) using an ophthalmic laser system, optical position monitoring of the IOL is performed by a video camera system viewing the top surface of the IOL. Fiducials are incorporated into the IOL at manufacture, or created in-vivo with laser. The monitoring method employs a defined area of interest (AOI) to limit the number of pixels to be analyzed, to achieve adequately high acquisition speed. In one example, the AOI contains 5 camera scan line segments, each line segment having sufficient pixels to create a stable amplitude signature. Successive frames of the AOI are analyzed to detect movement of the fiducial and/or to determine whether the fiducial has been lost.